As of 2026-05-21, the EV/EBITDA ratio of Kwality Pharmaceuticals Ltd (539997.BO) is 20.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 539997.BO's latest enterprise value is 22,198.60 mil INR. 539997.BO's TTM EBITDA according to its financial statements is 1,076.70 mil INR. Dividing these 2 quantities gives us the above 539997.BO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.3x - 10.7x | 9.5x |
| Forward P/E multiples | 6.3x - 9.9x | 7.3x |
| Fair Price | 698.99 - 1,137.68 | 863.90 |
| Upside | -66.2% - -44.9% | -58.2% |
| Date | EV/EBITDA |
| 2026-05-20 | 20.62 |
| 2026-05-19 | 20.09 |
| 2026-05-18 | 18.37 |
| 2026-05-15 | 17.29 |
| 2026-05-14 | 16.94 |
| 2026-05-13 | 16.80 |
| 2026-05-12 | 16.82 |
| 2026-05-11 | 17.29 |
| 2026-05-08 | 17.37 |
| 2026-05-07 | 17.27 |
| 2026-05-06 | 17.15 |
| 2026-05-05 | 16.74 |
| 2026-05-04 | 16.71 |
| 2026-04-30 | 15.79 |
| 2026-04-29 | 16.22 |
| 2026-04-28 | 16.10 |
| 2026-04-27 | 16.21 |
| 2026-04-24 | 16.31 |
| 2026-04-23 | 17.10 |
| 2026-04-22 | 16.52 |
| 2026-04-21 | 15.92 |
| 2026-04-20 | 16.71 |
| 2026-04-17 | 17.65 |
| 2026-04-16 | 16.93 |
| 2026-04-15 | 15.58 |
| 2026-04-13 | 15.14 |
| 2026-04-10 | 15.45 |
| 2026-04-09 | 15.24 |
| 2026-04-08 | 15.04 |
| 2026-04-07 | 15.12 |
| 2026-04-06 | 14.58 |
| 2026-04-02 | 14.23 |
| 2026-04-01 | 14.45 |
| 2026-03-30 | 13.34 |
| 2026-03-27 | 14.21 |
| 2026-03-25 | 14.69 |
| 2026-03-24 | 14.92 |
| 2026-03-23 | 14.69 |
| 2026-03-20 | 15.36 |
| 2026-03-19 | 15.80 |
| 2026-03-18 | 15.63 |
| 2026-03-17 | 16.09 |
| 2026-03-16 | 15.93 |
| 2026-03-13 | 16.02 |
| 2026-03-12 | 17.00 |
| 2026-03-11 | 16.61 |
| 2026-03-10 | 15.86 |
| 2026-03-09 | 15.55 |
| 2026-03-06 | 14.74 |
| 2026-03-05 | 15.07 |